Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of 4-MUST tablets in patients with chronic cholecystitis and biliary dyskinesia; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 4-MUST Tablets

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Chronic Cholecystitis, Biliary Dyskinesia | Phase 2 | Status: RECRUITING